Functional and Cognitive Improvement After an Intensive Inpatient Multidisciplinary Rehabilitation Program in Mild to Severe Parkinson's Disease: A Retrospective and Observational Study.
cognitive therapy
multidisciplinary program
neurorehabilitation
parkinson's disease
physical therapy
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2021
2021
Historique:
received:
04
11
2020
accepted:
03
02
2021
entrez:
5
4
2021
pubmed:
6
4
2021
medline:
6
4
2021
Statut:
epublish
Résumé
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor (resting tremor, rigidity, bradykinesia, postural instability, and gait disturbances) and nonmotor symptoms (cognitive, neuropsychiatric, and autonomic problems). In recent years, several studies demonstrated that neurorehabilitation therapy is an effective treatment in addition to pharmacological personalized interventions in persons with PD (PwPD). The main aim of this study was to explore the short-term changes in functional, cognitive, and geriatric domains after a multidimensional rehabilitation program in PwPD (as primary condition) in mild-moderate (M-Ms) to severe (Ss) stages. Our second aim was to compare the effects of multidimensional rehabilitation in M-Ms versus Ss of PD. Twenty-four PwPD in M-Ms to Ss [age (mean ± SD) = 76.25 ± 9.42 years; male/female = 10/14; Hoehn and Yahr (median; IQR) = 4.00; 1.75] were included in a retrospective, observational study. Motor, cognitive, functional, and neuropsychiatric aspects were collected in admission (T0) and in discharge (T1). PwPD were involved in a person-tailored (to individual's needs), inpatient, intensive (5-7 days per week), multidisciplinary (combining cognitive, physical, occupational, and speech therapies), comprehensive, and rehabilitative program. According to Movement Disorders Society Unified Parkinson's Disease Rating Scale III cutoff, PwPD were classified in M-Ms or Ss (M-Ms ≤59; Ss >59); 87.50% of our sample reported significant reduction of functional disability at Barthel Index (
Identifiants
pubmed: 33815253
doi: 10.3389/fneur.2021.626041
pmc: PMC8012662
doi:
Types de publication
Journal Article
Langues
eng
Pagination
626041Informations de copyright
Copyright © 2021 Meloni, Saibene, Di Tella, Di Cesare, Borgnis, Nemni and Baglio.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Arch Phys Med Rehabil. 2001 Apr;82(4):509-15
pubmed: 11295012
Disabil Rehabil Assist Technol. 2018 Aug;13(6):575-580
pubmed: 28758517
Front Neurol. 2011 Dec 22;2:82
pubmed: 22203816
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Eur Neurol. 1996;36(6):378-84
pubmed: 8954307
Neurol Sci. 2014 Aug;35(8):1173-80
pubmed: 24554416
Phys Ther. 2008 Jul;88(7):812-9
pubmed: 18436568
J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):828-835
pubmed: 29321141
Phys Ther. 2007 Sep;87(9):1120-31
pubmed: 17609332
Neurorehabil Neural Repair. 2012 Feb;26(2):144-50
pubmed: 21844282
Pain Pract. 2003 Dec;3(4):310-6
pubmed: 17166126
Arch Clin Neuropsychol. 2017 Nov 1;32(7):840-860
pubmed: 28961738
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Parkinsonism Relat Disord. 2009 Jan;15(1):6-11
pubmed: 18424221
Mov Disord. 2009 Jan 15;24(1):1-14
pubmed: 18946880
Curr Neurol Neurosci Rep. 2014 Nov;14(11):493
pubmed: 25245121
Mov Disord. 2015 Jul;30(8):1050-8
pubmed: 26095443
Turk J Emerg Med. 2018 Aug 07;18(3):91-93
pubmed: 30191186
Neurol Sci. 2018 Jan;39(1):141-143
pubmed: 28956175
Front Syst Neurosci. 2019 Feb 11;13:7
pubmed: 30804762
J Am Geriatr Soc. 1968 May;16(5):622-6
pubmed: 5646906
JAMA Neurol. 2018 Feb 1;75(2):219-226
pubmed: 29228079
Biomed Res Int. 2016;2016:3596415
pubmed: 27314016
Neurology. 2014 Dec 2;83(23):2167-74
pubmed: 25361785
Cochrane Database Syst Rev. 2013 Sep 10;(9):CD002817
pubmed: 24018704
Arch Phys Med Rehabil. 2005 Apr;86(4):626-32
pubmed: 15827910
Neurol Sci. 2002 Mar;22(6):443-7
pubmed: 11976975
Front Neurol. 2019 May 07;10:419
pubmed: 31133956
Mov Disord. 2015 Sep 15;30(11):1504-20
pubmed: 26274930
Ital J Neurol Sci. 1987 Dec;Suppl 8:1-120
pubmed: 3330072
Parkinsonism Relat Disord. 2015 Jan;21(1):50-4
pubmed: 25466406
Eur J Neurol. 2018 Jan;25(1):5-12
pubmed: 28940855
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Brain Behav. 2018 Oct;8(10):e01094
pubmed: 30160376
Comput Struct Biotechnol J. 2016 Nov 27;15:68-74
pubmed: 27994799
JAMA. 2020 Feb 11;323(6):548-560
pubmed: 32044947
Mov Disord. 2012 Apr 15;27(5):617-26
pubmed: 22508280
J Geriatr Psychiatry Neurol. 2012 Dec;25(4):208-14
pubmed: 23172765
Medsurg Nurs. 1999 Dec;8(6):348-54
pubmed: 11000772
Mov Disord. 2010;25 Suppl 1:S141-5
pubmed: 20187247
Mov Disord. 2008 Apr 15;23(5):631-40
pubmed: 18181210
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S73-7
pubmed: 26362955
Eur J Neurol. 1996 May;3(3):198-202
pubmed: 21284770